Eldrin Foster Lewis

机构：Brigham and Women's Hospital, Palo Alto University, Cardiovascular Institute of the South, Stanford Medicine, Morehouse School of Medicine, Stanford University · ORCID：0000-0002-5147-9512

发表论文 394 篇 · 总被引 36666 次 · h-index 77

代表论文

• Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial (2025 · The Lancet · 被引 84)
• Heart Disease Mortality in the United States, 1970 to 2022 (2025 · Journal of the American Heart Association · 被引 53)
• Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials (2025 · The Lancet · 被引 46)
• Access to digital health technologies: personalized framework and global perspectives (2025 · Nature Reviews Cardiology · 被引 31)
• Effect of Vericiguat on Total Heart Failure Events in Compensated Outpatients With HFrEF (2025 · Journal of the American College of Cardiology · 被引 21)
• Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trial (2025 · European Heart Journal · 被引 21)